Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex

BM Palmer, Y Wang, P Teekakirikul… - American Journal …, 2008 - journals.physiology.org
BM Palmer, Y Wang, P Teekakirikul, JT Hinson, D Fatkin, S Strouse, P VanBuren
American Journal of Physiology-Heart and Circulatory Physiology, 2008journals.physiology.org
Male but not female mice carrying a single R403Q missense allele for cardiac α-myosin
heavy chain (M-αMHCR403Q/+ and F-αMHCR403Q/+, respectively) develop significant
hypertrophic cardiomyopathy (HCM) compared with male and female wild-type mice (M-
αMHC+/+ and F-αMHC+/+, respectively) after∼ 30 wk of age. We tested the hypothesis that
myofilament mechanical performance differs between M-αMHCR403Q/+ and F-
αMHCR403Q/+ at younger ages (10–20 wk) and could account for sex differences in HCM …
Male but not female mice carrying a single R403Q missense allele for cardiac α-myosin heavy chain (M-αMHCR403Q/+ and F-αMHCR403Q/+, respectively) develop significant hypertrophic cardiomyopathy (HCM) compared with male and female wild-type mice (M-αMHC+/+ and F-αMHC+/+, respectively) after ∼30 wk of age. We tested the hypothesis that myofilament mechanical performance differs between M-αMHCR403Q/+ and F-αMHCR403Q/+ at younger ages (10–20 wk) and could account for sex differences in HCM development. The sensitivity of chemically skinned myocardial strips to Ca2+ activation (pCa50) was significantly (P < 0.05) enhanced in male mice independent of genotype (M-αMHCR403Q/+: 5.70 ± 0.06, M-αMHC+/+: 5.63 ± 0.05, F-αMHCR403Q/+: 5.57 ± 0.03, F-αMHC+/+: 5.54 ± 0.04) by two-way ANOVA, whereas maximum developed tension was significantly enhanced in α-MHCR403Q/+ independent of sex (M-αMHCR403Q/+: 29.3 ± 2.3, M-αMHC+/+: 26.0 ± 1.4, F-αMHCR403Q/+: 30.2 ± 2.1, F-αMHC+/+: 26.2 ± 1.2 mN/mm2). The frequency of maximum work generated by sinusoidal length perturbation was significantly higher in αMHCR403Q/+ mice than in sex-matched controls (M-αMHCR403Q/+: 2.26 ± 0.47, M-αMHC+/+: 1.29 ± 0.18, F-αMHCR403Q/+: 3.21 ± 0.33, F-αMHC+/+: 2.52 ± 0.36 Hz). Unloaded shortening velocity was significantly enhanced in αMHCR403Q/+ and in female mice (M-αMHCR403Q/+: 2.26 ± 0.47, M-αMHC+/+: 1.29 ± 0.18, F-αMHCR403Q/+: 3.21 ± 0.33, F-αMHC+/+: 2.52 ± 0.36 muscle lengths/s), and normalized mechanical power, calculated from the tension-velocity relationship, was significantly enhanced in αMHCR403Q/+ independent of sex (M-αMHCR403Q/+: 60 ± 2 10−3, M-αMHC+/+: 37 ± 3 10−3, F-αMHCR403Q/+: 57 ± 3 10−3, F-αMHC+/+ 25 ± 3 10−3 muscle lengths/s × normalized tension). We did not find a statistically significant sex × mutation interaction for any measure of myofilament performance. Therefore, sarcomeric incorporation of the R403Q myosin similarly enhanced left ventricular myofilament mechanical performance in both male and female mice. The sex-dependent development of HCM due to the R403Q myosin may then be inhibited by female sex hormones, which may additionally underlie the observed sex differences for pCa50 and unloaded shortening velocity.
American Physiological Society